George S.N. Hui to Vaccines, Synthetic
This is a "connection" page, showing publications George S.N. Hui has written about Vaccines, Synthetic.
Connection Strength
0.503
-
Hui G, Hashimoto C. Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes. Vaccine. 2007 Jan 15; 25(5):948-56.
Score: 0.280
-
Pusic K, Aguilar Z, McLoughlin J, Kobuch S, Xu H, Tsang M, Wang A, Hui G. Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine. FASEB J. 2013 Mar; 27(3):1153-66.
Score: 0.107
-
Yuen D, Leung WH, Cheung R, Hashimoto C, Ng SF, Ho W, Hui G. Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development. Vaccine. 2007 Jan 05; 25(3):490-9.
Score: 0.069
-
Hui GS, Nikaido C, Hashiro C, Kaslow DC, Collins WE. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys. Infect Immun. 1996 May; 64(5):1502-9.
Score: 0.034
-
Pang AL, Hashimoto CN, Tam LQ, Meng ZQ, Hui GS, Ho WK. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system. Infect Immun. 2002 Jun; 70(6):2772-9.
Score: 0.013